Search Results - "Raskopf, E." :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Lolium perenne peptide immunotherapy is well tolerated and elicits a protective B‐cell response in seasonal allergic rhinitis patients

Lolium perenne peptide immunotherapy is well tolerated and elicits a protective B‐cell response in seasonal allergic rhinitis patients

by Mösges, R., Koch, A. F., Raskopf, E., Singh, J., Shah‐Hosseini, K., Astvatsatourov, A., Hauswald, B., Yarin, Y., Corazza, F., Haazen, L., Pirotton, S., Allekotte, S., Zadoyan, G., Legon, T., Durham, S. R., Shamji, M. H.
Published in Allergy (Copenhagen) (01.06.2018)

Get full text

Journal Article

A randomized, double‐blind, placebo‐controlled, dose‐finding trial with Lolium perenne peptide immunotherapy

A randomized, double‐blind, placebo‐controlled, dose‐finding trial with Lolium perenne peptide immunotherapy

by Mösges, R., Kasche, E. M., Raskopf, E., Singh, J., Sohlich, L., Astvatsatourov, A., Shah‐Hosseini, K., Pirotton, S., Haazen, L., Durham, S. R., Legon, T., Zadoyan, G., Shamji, M. H.
Published in Allergy (Copenhagen) (01.04.2018)

Get full text

Journal Article

RCAT reflects symptom control and quality of life in allergic rhinoconjunctivitis patients

RCAT reflects symptom control and quality of life in allergic rhinoconjunctivitis patients

by Liedtke, J.‐P., Mandl, A., Köther, J., Chwieralski, J., Shah‐Hosseini, K., Raskopf, E., Pieper‐Fürst, U., Allekotte, S., Mösges, R.
Published in Allergy (Copenhagen) (01.05.2018)

Get full text

Journal Article

P0241 : CD40/CD40Ligand interaction between tumor lysate-pulsed dendritic cells induces a Th1-environment and enhances the cytotoxic activity of immunologic effector cells towards human hepatocellular carcinoma and cholangiocellular carcinoma cells

P0241 : CD40/CD40Ligand interaction between tumor lysate-pulsed dendritic cells induces a Th1-environment and enhances the cytotoxic activity of immunologic effector cells towards human hepatocellular carcinoma and cholangiocellular carcinoma cells

by Vogt, A, Hillebrand, R.M, Raskopf, E, Schmidt-Wolf, I.G, Strassburg, C.P, Gonzalez-Carmona, M.A
Published in Journal of hepatology (01.04.2015)

Get full text

Journal Article

303 PLASMINOGEN K1-5 STRONGLY DECREASES INTRAHEPATIC SPREAD AND TUMOUR GROWTH IN AN EXPERIMENTAL MOUSE FIBROSIS MODEL

303 PLASMINOGEN K1-5 STRONGLY DECREASES INTRAHEPATIC SPREAD AND TUMOUR GROWTH IN AN EXPERIMENTAL MOUSE FIBROSIS MODEL

by Raskopf, E, Sauerbruch, T, Schmitz, V
Published in Journal of hepatology (01.04.2012)

Get full text

Journal Article

681 THE COMBINATION OF NEXAVAR AND SIRNA-VEGF INHIBITS THE NEXAVAR-INDUCED INCREASE OF VEGF RESULTING IN ENHANCED ANGIOSTATIC EFFECTS

681 THE COMBINATION OF NEXAVAR AND SIRNA-VEGF INHIBITS THE NEXAVAR-INDUCED INCREASE OF VEGF RESULTING IN ENHANCED ANGIOSTATIC EFFECTS

by Raskopf, E, Sauerbruch, T, Schmitz, V
Published in Journal of hepatology (01.03.2011)

Get full text

Journal Article

891 PLASMINOGEN K1–5 STRONGLY REDUCES TUMOUR GROWTH VIA DUAL ANTIANGIOGENIC AND ANTITUMOURAL EFFECTS IN VITRO AND IN VIVO

891 PLASMINOGEN K1–5 STRONGLY REDUCES TUMOUR GROWTH VIA DUAL ANTIANGIOGENIC AND ANTITUMOURAL EFFECTS IN VITRO AND IN VIVO

by Raskopf, E, Vogt, A, Sauerbruch, T, Schmitz, V
Published in Journal of hepatology (2010)

Get full text

Journal Article

Inhibition of neuropilin-1 by RNA-interference and its angiostatic potential in the treatment of hepatocellular carcinoma

Inhibition of neuropilin-1 by RNA-interference and its angiostatic potential in the treatment of hepatocellular carcinoma

by Raskopf, E, Vogt, A, Standop, J, Sauerbruch, T, Schmitz, V
Published in Zeitschrift fur Gastroenterologie (01.01.2010)

Get more information

Journal Article

376 STATINS INDUCE SENESCENCE OF ACTIVATED HSC BY INHIBITION OF THE HEDGEHOG PATHWAY

376 STATINS INDUCE SENESCENCE OF ACTIVATED HSC BY INHIBITION OF THE HEDGEHOG PATHWAY

by Klein, S, Granzow, M, Schierwagen, R, Van der Ven, P, Raskopf, E, Pieper-Fürst, U, Fürst, D, Lammert, F, Choi, S, Diehl, A.M, Shah, V, Sauerbruch, T, Trebicka, J
Published in Journal of hepatology (01.04.2012)

Get full text

Journal Article

864 COMBINING SUBCUTANEOUS INOCULATION OF AFP-EXPRESSING DC WITH INTRAPERITONEAL INJECTION OF IL-12-EXPRESSING DC INCREASES SURVIVAL IN AN ESTABLISHED ORTHOTOPIC HCC MODEL

864 COMBINING SUBCUTANEOUS INOCULATION OF AFP-EXPRESSING DC WITH INTRAPERITONEAL INJECTION OF IL-12-EXPRESSING DC INCREASES SURVIVAL IN AN ESTABLISHED ORTHOTOPIC HCC MODEL

by Decker, G, Vogt, A, Bahadori, I, Raskopf, E, Schmitz, V, Sauerbruch, T, Caselmann, W.H, Gonzalez-Carmona, M.A
Published in Journal of hepatology (2010)

Get full text

Journal Article

906 INHIBITION OF TUMOR GROWTH AFTER SUBCUTANEOUS INJECTION OF DENDRITIC CELLS ENGINEERED TO EXPRESS ANGIOGENESIS-RELATED FLK-1 ANTIGEN IN A MURINE HCC MODEL

906 INHIBITION OF TUMOR GROWTH AFTER SUBCUTANEOUS INJECTION OF DENDRITIC CELLS ENGINEERED TO EXPRESS ANGIOGENESIS-RELATED FLK-1 ANTIGEN IN A MURINE HCC MODEL

by Vogt, A, Decker, G, Raskopf, E, Schmitz, V, Sauerbruch, T, Caselmann, W.H, González-Carmona, M.A
Published in Journal of hepatology (2010)

Get full text

Journal Article

542 STATIN TREATMENT DECREASE COLLATERAL FLOW AND PORTAL PRESSURE IN CIRRHOSIS, BUT NOT IN PREHEPATIC PORTAL HYPERTENSION

542 STATIN TREATMENT DECREASE COLLATERAL FLOW AND PORTAL PRESSURE IN CIRRHOSIS, BUT NOT IN PREHEPATIC PORTAL HYPERTENSION

by Trebicka, J, Klein, S, Granzow, M, Ranabhat, G, Hennenberg, M, Raskopf, E, Gautsch, S, Schmitz, V, Sauerbruch, T
Published in Journal of hepatology (2010)

Get full text

Journal Article

546 POSTTRANSCRIPTIONAL VEGF INHIBITION LEADS TO ANGIOSTATIC EFFECTS IN VITRO AND IN VIVO

546 POSTTRANSCRIPTIONAL VEGF INHIBITION LEADS TO ANGIOSTATIC EFFECTS IN VITRO AND IN VIVO

by Raskopf, E, Vogt, A, Kornek, M, Sauerbruch, T, Schmitz, V
Published in Journal of hepatology (2008)

Get full text

Journal Article

[196] EXPERIMENTAL ORTHOTOPIC HCC GROWTH IS ACCELERATED IN HEPATIC FIBROSIS

[196] EXPERIMENTAL ORTHOTOPIC HCC GROWTH IS ACCELERATED IN HEPATIC FIBROSIS

by Kornek, M, Raskopf, E, Tolba, R, Sauerbruch, T
Published in Journal of hepatology (2007)

Get full text

Journal Article

309 CYTOTOXIC ACTIVITY OF IMMUNOLOGIC EFFECTOR CELLS INDUCED AGAINST HCC BY AFP- OR TUMOR LYSATE-PULSED DENDRITIC CELLS CAN BE SIGNIFICANTLY ENHANCED BY ADENOVIRAL TRANSDUCTION WITH IL-12

309 CYTOTOXIC ACTIVITY OF IMMUNOLOGIC EFFECTOR CELLS INDUCED AGAINST HCC BY AFP- OR TUMOR LYSATE-PULSED DENDRITIC CELLS CAN BE SIGNIFICANTLY ENHANCED BY ADENOVIRAL TRANSDUCTION WITH IL-12

by Gonzalez-Carmona, M.A, Vogt, A, Sievers, E, Raskopf, E, Schmidt-Wolf, I, Schmitz, V, Sauerbruch, T, Caselmann, W.H
Published in Journal of hepatology (2009)

Get full text

Journal Article

335 VEGF-A GENE SILENCING AND IMMUNOSTIMULATION COMBINED IN ONE SIRNA INCREASED ANTI TUMORAL THERAPY EFFICACY IN AN HCC ORTHOTOPIC FIBROTIC TUMOR MODEL

335 VEGF-A GENE SILENCING AND IMMUNOSTIMULATION COMBINED IN ONE SIRNA INCREASED ANTI TUMORAL THERAPY EFFICACY IN AN HCC ORTHOTOPIC FIBROTIC TUMOR MODEL

by Kornek, M, Lukacs-Kornek, V, Raskopf, E, Limmer, A, Sauerbruch, T, Schmitz, V
Published in Journal of hepatology (2008)

Get full text

Journal Article

[392] POSTTRANSCRIPTIONAL VEGF INHIBITION REDUCES TUMOR GROWTH IN AN EXPERIMENTAL MURINE HCC MODEL

[392] POSTTRANSCRIPTIONAL VEGF INHIBITION REDUCES TUMOR GROWTH IN AN EXPERIMENTAL MURINE HCC MODEL

by Raskopf, E, Vogt, A, Kornek, M, Sauerbruch, T, Schmitz, V
Published in Journal of hepatology (2007)

Get full text

Journal Article

Increased VEGF levels induced by anti-VEGF treatment are independent of tumor burden in colorectal carcinomas in mice

Increased VEGF levels induced by anti-VEGF treatment are independent of tumor burden in colorectal carcinomas in mice

by SCHMITZ, V, VILANUEVA, H, PRIETO, J, CASELMANN, W. H, QIAN, C, RASKOPF, E, HILBERT, T, BARAJAS, M, DZIENISOWICZ, C, GORSCHLÜTER, M, STREHL, J, RABE, C, SAUERBRUCH, T
Published in Gene therapy (01.08.2006)

Get full text

Journal Article

[387] INTRATUMORAL TREATMENT OF PRE-ESTABLISHED SUBCUTANEOUS HEPATOCELLULAR TUMORS WITH TUMOR LYSATE PUSED DENDRITIC CELLS ENGINEERED TO EXPRESS CD40L CONFERS HIGHER ANTITUMOR IMMUNITY THAN SUBCUTANEOUS OR INTRAVENOUS TREATMENT

[387] INTRATUMORAL TREATMENT OF PRE-ESTABLISHED SUBCUTANEOUS HEPATOCELLULAR TUMORS WITH TUMOR LYSATE PUSED DENDRITIC CELLS ENGINEERED TO EXPRESS CD40L CONFERS HIGHER ANTITUMOR IMMUNITY THAN SUBCUTANEOUS OR INTRAVENOUS TREATMENT

by Gonzalez-Carmona, M.A, Timmerman, A, Raskopf, E, Kornek, M, Schmidt-Wolf, I.G, Caselmann, W.H, Sauerbruch, T, Schmitz, V
Published in Journal of hepatology (2007)

Get full text

Journal Article

205 COMBINED IMMUNOTHERAPY WITH IL12-EXPRESSING DENDRITIC CELLS AND AFP-PULSED DC TOWARDS ESTABLISHED HEPATOCELLULAR CARCINOMA

205 COMBINED IMMUNOTHERAPY WITH IL12-EXPRESSING DENDRITIC CELLS AND AFP-PULSED DC TOWARDS ESTABLISHED HEPATOCELLULAR CARCINOMA

by Decker, G, Vogt, A, Raskopf, E, Schmitz, V, Caselmann, W.H, Sauerbruch, T, Gonzalez-Carmona, M.A
Published in Journal of hepatology (01.03.2011)

Get full text

Journal Article